본문으로 건너뛰기
← 뒤로

Prostate Specific Antigen (PSA) Testing and Cancer Detection: Guidance Notes for the Non-Urologist.

British journal of hospital medicine (London, England : 2005) 2025 Vol.86(6) p. 1-5

Juliebø-Jones P, Beisland C

📝 환자 설명용 한 줄

Prostate cancer is the most frequently diagnosed cancer in men and is a leading cause of cancer-related deaths.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Juliebø-Jones P, Beisland C (2025). Prostate Specific Antigen (PSA) Testing and Cancer Detection: Guidance Notes for the Non-Urologist.. British journal of hospital medicine (London, England : 2005), 86(6), 1-5. https://doi.org/10.12968/hmed.2024.1035
MLA Juliebø-Jones P, et al.. "Prostate Specific Antigen (PSA) Testing and Cancer Detection: Guidance Notes for the Non-Urologist.." British journal of hospital medicine (London, England : 2005), vol. 86, no. 6, 2025, pp. 1-5.
PMID 40554445

Abstract

Prostate cancer is the most frequently diagnosed cancer in men and is a leading cause of cancer-related deaths. Prostate specific antigen (PSA) is one of the key tests that can aid in making such a diagnosis. It is, however, a test with both advantages and disadvantages. Despite having been a part of clinical practice for over 40 years, its use still represents many challenges. Clinicians across all specialties can benefit from gaining deeper insight into how it can be effectively integrated into their practice.

MeSH Terms

Humans; Male; Early Detection of Cancer; Practice Guidelines as Topic; Prostate-Specific Antigen; Prostatic Neoplasms